Influenza – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Influenza is a respiratory disease caused by influenza viruses belonging to genera influenzavirus A and B, with additionally known genera of influenzavirus C and D. Symptoms of influenza infection range from mild upper respiratory disease with fever, sore throat, runny nose, cough, headache, muscle pain, and fatigue to severe pneumonia caused by the virus or secondary bacterial infection of the lower respiratory tract. Influenza virus infection may also cause non-respiratory complications affecting other organ systems, including the heart and central nervous system. Young children and older adults are at increased risk for severe illness and infectious complications. Children who have not previously been exposed to influenza viruses are highly susceptible to infection and may have more severe symptoms with longer shedding periods of the virus.
·
According to estimates, the United States has
faced a considerable burden of influenza, with around 9 million cases of flu, 4
million flu-related medical visits, 100,000 hospitalizations, and approximately
5,000 deaths.
·
Seasonal epidemics of influenza A and B
viruses cause the majority of disease burden in humans, with most infections
occurring in children and severe cases primarily affecting very young and
elderly individuals.
Thelansis’s “Influenza Market Outlook,
Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To
2032" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Influenza treatment modalities options for
eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Influenza across 8 MM market from the centre of Excellence/ Public/ Private
hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Influenza Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment